| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| R&D Expense | $175K | -75.4% |
| SG&A Expense | $347K | +147.5% |
| Operating Income | -$745K | +45.7% |
| Interest Expense | $21K | +1180.2% |
| Pre-tax Income | -$585K | +57.4% |
| Income Tax | $0 | — |
| Net Income | -$585K | +57.4% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Current Assets | $106K | -59.3% |
| Total Assets | $106K | -59.3% |
| Current Liabilities | $2.7M | +6.2% |
| Total Liabilities | $2.7M | +6.2% |
| Stockholders' Equity | -$2.6M | -13.8% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$110K | -24.7% |
| Investing Cash Flow | $0 | — |
| Financing Cash Flow | $93K | -7.0% |